New target identified for pancreatic cancer treatment
Researchers have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
Sep 26, 2023
0
58
Researchers have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
Sep 26, 2023
0
58
Liver cancer is one of the most prevalent and deadly types of cancer worldwide. Most patients are diagnosed at an advanced stage, which leaves them with few treatment options. Unfortunately, the first-line drugs used in advanced ...
Sep 20, 2023
0
1
The risk of death from breast cancer is 43% higher for women who had at least one treatment interval longer than the recommended treatment timeframes, according to new research.
Sep 18, 2023
0
1
Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), ...
Sep 14, 2023
0
66
A standard chemotherapy drug injures surrounding non-cancer cells, which can then awaken dormant cancer cells and promotes cancer growth, according to a new study publishing September 12 in the open access journal PLoS Biology ...
Sep 12, 2023
0
81
Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to osimertinib alone, according to research presented at the International Association ...
Sep 11, 2023
0
7
The combination of benmelstobart, anlotinib, and chemotherapy demonstrated significant benefits compared to placebo and chemotherapy in terms of median progression-free survival and overall survival for patients with extensive-stage ...
Sep 11, 2023
0
1
Research findings from the CheckMate 227 trial will be presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2023 in Singapore, shedding light on the six-year survival ...
Sep 9, 2023
0
1
A new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer.
Sep 8, 2023
0
3
Researchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination with the drugs nivolumab, and regorafenib.